The study on anticancer effects and mechanisms of compositions from Chinese materia medica in vivo is very necessary for new drug development. 通過(guò)動(dòng)物實(shí)驗研究中藥抗腫瘤作用及機制是新藥開(kāi)發(fā)的必要途徑。
Because of small content in the plant, complicated extracting procedure and poor purity, the process of new drug R&D based on Danshensu has been hampered acutely. 然而，丹參素在植物中的含量甚少，提取工藝復雜且純度不高，這嚴重阻礙了以其為基礎的新藥開(kāi)發(fā)進(jìn)程。
